News stories about "RSV" in India.

RSV Can Be a Killer. New Tools Are Identifying the Most At-Risk Kids

RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning and statistical models are identifying those most at risk. Key Points

WIRED

US gets 3rd vaccine against highly contagious Respiratory virus RSV. How India can benefit from these

Approval for Moderna’s mRESVIA is the 1st time an mRNA vaccine has been approved for a disease other than Covid. This could be crucial for India where RSV's a major public health challenge. Key Points

ThePrint

What is RSV affecting children this winter? Know about symptoms and treatment

Respiratory Syncytial Virus or RSV is a viral disease that infects young children. The disease shows mild symptoms but can be serious and lead to hospitalization of the patients. Young children and the elderly are more vulnerable to the virus. Key Points

Economic Times

CDC expedites release of 77,000 additional doses of Sanofi-AstraZeneca's RSV drug

The U.S. Centers for Disease Control and Prevention said on Thursday it has expedited the release of more than 77,000 additional doses of Sanofi (SASY.PA) and AstraZeneca's (AZN.L) respiratory syncytial virus (RSV) drug Beyfortus. Key Points

Reuters

AstraZeneca prioritizes US for RSV drug amid surge in cases

AstraZeneca (AZN.L) on Friday said it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus, which was approved in July to prevent the disease in infants and toddlers, as a surge of cases is outpacing supply. Key Points

Reuters

The RSV vaccine for pregnant moms FDA approved: what to know

A doctor says she feels 'powerless' against RSV — a 'terrifying' virus that kills hundreds of babies a year. She's overjoyed that the FDA just approved a vaccine for it. Key Points

Insider

Factbox: US FDA approves Pfizer RSV vaccine a month after greenlighting GSK shot

Pfizer Inc late on Wednesday received the U.S. Food and Drug Administration's nod for its respiratory syncytial virus (RSV) vaccine for older adults, nearly a month after GSK's shot was approved by the regulator. Key Points

Reuters

Researchers reveal early RSV infection associated to increased risk of asthma in children

Washington [US], April 24 (ANI): The development of childhood wheezing illnesses has long been linked to severe respiratory syncytial virus (RSV) infection, but the connection between RSV infection during infancy and the emergence of childhood asthma has remained unclear. The findings of the study was published in the journal The Lancet. Researchers at Vanderbilt University […] Key Points

ThePrint

US CDC OKs use of new Pfizer, GSK vaccines for RSV in older adults

The director of the U.S. Centers for Disease Control and Prevention on Thursday signed off on the use of new vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infections in older adults. Key Points

Reuters

Pfizer RSV vaccine lags GSK’s as head-to-head competition underway

Pfizer (PFE.N), which dominated COVID vaccine sales, now finds itself looking up at GSK (GSK.L), whose rival new respiratory syncytial virus (RSV) vaccine has surged to an early lead since the shots launched this summer. Key Points

Reuters

AstraZeneca to buy RSV vaccine maker Icosavax for up to $1.1 bln

Drugmaker AstraZeneca (AZN.L) on Tuesday agreed to buy vaccine developer Icosavax (ICVX.O) in a deal valued at up to $1.1 billion to bolster its respiratory syncytial virus (RSV) vaccine portfolio. Key Points

Reuters